CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE: Release of a capital market information
CompuGroup Medical SE / Share Buyback 03.09.2018 / 13:41 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 7th Interim Announcement CompuGroup Medical SE / Share Buyback Koblenz, September 3, 2018 CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 7th Interim Announcement In the period from August 27, 2018, up to and including August 31, 2018, CompuGroup Medical SE has bought back a total of 35,547 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of July 13, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on July 16, 2018. The overall volume of the shares bought back daily in the period from August 27, 2018, up to and including August 31, 2018, and the daily volume- weighted average stock market prices of the shares are as follows:Date Overall volume of Volume-weighted average stock shares bought back market price (number) (EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice) August 27, 2018 5,254 50.9603 August 28, 2018 7,300 51.1479 August 29, 2018 9,218 51.4979 August 30, 2018 3,350 50.9918 August 31, 2018 10,425 50.1905 In total: 35,547 50.9154The total number of shares which have been bought back so far by CompuGroup Medical SE since July 16, 2018, up to and including August 31, 2018, within the framework of the share buyback program thus amounts to 258,624 no-par value shares. Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb. The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading). Koblenz, September 3, 2018 The Management Board CompuGroup Medical SE Investor Relations Maria Trost 21 56070 Koblenz, Germany T: 49 (0) 261 8000-6200 F: 49 (0) 261 8000-3200 --------------------------------------------------------------------------- 03.09.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: CompuGroup Medical SE Maria Trost 21 56070 Koblenz Germany Internet: www.cgm.com End of News DGAP News Service
Latest News
Latest Reports
Upcoming Events
Event Functions
Additional Functions
Webcasts
No Webcasts found